Transcervical resection of endometrium and fibroids: The outcome of 412 operations performed over 5 years

Istre, Olav

doi:10.3109/00016349609054673

Cited by 38 publications

(36 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In case of excessive absorption isotonic glycine 2.2% (22 g glycine in 1,000 ml) may result in more pronounced side effects compared to hypotonic glycine 1.5% (15 g glycine in 1,000 ml). However, in previous studies severe adverse symptoms of hypotonic glycine were not described [11][12][13]18]. They also were not found in this study in which isotonic glycine was used.…”

Section: Discussioncontrasting

confidence: 58%

See 1 more Smart Citation

Experience with Isotonic 2.2% Glycine as Distension Medium for Hysteroscopic Endomyometrial Resection

Tapper

Heinonen²

1999

Gynecol Obstet Invest

View full text Add to dashboard Cite

The feasibility of performing hysteroscopic endomyometrial resection using isotonic 2.2% glycine as distension medium was studied in 181 consecutive operations. A standard continuous flow loop-resectoscope was used. Distension was achieved by means of a gravity-fed system and glycine flowed out under its own pressure. The mean (±SEM) glycine deficit was 160 ± 20 ml and in only 7 patients was it >1 liter (maximum 1,800 ml). Only in patients with >1 liter glycine absorption was there a significant decrease in serum sodium level (mean 9 mmol/l), while serum osmolality remained normal. Apart from 1 case of transient nausea, these patients had no sequelae. We experienced isotonic 2.2% glycine as a useful and safe distending medium for operative hysteroscopy.

show abstract

Section: Discussioncontrasting

confidence: 58%

“…The distending media commonly used in hysteroscopic surgery are hypotonic, the most widely used being 1.5% glycine [11][12][13]. This is the first study to evaluate the use of isotonic 2.2% glycine as a distension medium for hysteroscopic surgery.…”

Section: Discussionmentioning

confidence: 99%

Experience with Isotonic 2.2% Glycine as Distension Medium for Hysteroscopic Endomyometrial Resection

Tapper

Heinonen²

1999

Gynecol Obstet Invest

View full text Add to dashboard Cite

show abstract

“…Alguns autores observaram que a presença de miomas submucosos, principalmente aqueles com mais de 50% de componente intramural, operados no mesmo ato que a ressecção é um fator que favorece o insucesso da ablação endometrial 6,15 . Apenas 8,3% de nossas pacientes apresentavam miomas com componente submucoso e nosso índice de resultados favoráveis (88,3%) parece ainda estar dentro de limites esperados.…”

Section: Discussionunclassified

“…A perfuração uterina, cujos índices chegam a 3% 4,6,16 , podem ser acompanhadas de outras lesões maiores de vísceras abdominais 6 . Nessa casuística 5 pacientes tiveram perfuração uterina (8,3%).…”

Section: Discussionunclassified

Redução Endometrial por Vídeo-Histeroscopia: experiência em um Hospital de Ensino

Barbosa

Santos

Napolitano

et al. 1998

Rev. Bras. Ginecol. Obstet.

View full text Add to dashboard Cite

“…Three numerical systems were used: the bleeding index and bleeding score/month and the PBAC: Total bleeding score / month = summation of daily scores [19] (Score 0 No bleeding, Score 1 Spotting 1 pad/day, Score 2 Mild bleeding 2 pads/day, Score 3 Moderate bleeding 3-4 pads/day, Score 4 Severe bleeding 5-6 pads/day). In addition, the PBAC was used to assess the amount of blood loss.…”

Section: Assessment Of Menstrual Blood Lossmentioning

confidence: 99%

The Use of Levonorgestrel-Releasing System (Metraplant-E) in the Treatment of Abnormal Uterine Bleeding

Hussein

Rashid

Azzam

et al. 2018

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: Dysfunctional uterine bleeding (DUB) is one of the commonest condition for which patient seeks out medical consultation. The prevalence increases with the increase of age peaking before menopause. Objective: The aim of this work is to evaluate the effect of this new form of levonorgestrel-releasing IUD on the treatment of patients with abnormal uterine bleeding. Subjects and methods: A prospective age-specific comparative analysis of 61 peri-menopausal women presented with dysfunctional uterine bleeding who constituted the study group. They underwent hysteroscopy and endometrial sampling during an 18 months period from June 2014 to January 2016 at Ain Shams University Materity Hospital. Prior to metraplant-E application, all the patients in this study were in the age of 25-58 years old. Results: The role of Metraplant-E in the treatment of abnormal uterine bleeding (AUB) was evaluated. Sixty-one women with failed attempt(s) of medical treatment unwilling or unfit for hysterectomy were treated with Metaplant-E. Menstrual blood loss was assessed by pictoral bleeding assessment chart (PBAC), bleeding index (B.I) and total bleeding score (T.B.S/month). The bleeding patterns in the form of the mean menstrual blood loss estimated by bleeding index and the mean menstrual loss estimated by the total bleeding score/month and PBAC decreased significantly (p = 0.001). The quality of life scale (Likert scale) improved significantly (p = 0.001). All 15 cases who had endometrial sampling demonstrated progestational effect on histo-pathological examination. Conclusion: Metraplant-E was found to be effective in managing dysfunctional menorrhagia on both clinical and histopathological levels. Keywords: Metraplant-E, LNG-IUS, Menorrhagia, Contraceptives INTRODUCTIONDysfunctional uterine bleeding (DUB) is one of the commonest condition for which patient seeks out medical consultation. The prevalence increases with the increase of age peaking before menopause. The peri-menopausal women who have anovulatory cycle resulting in DUB. The normal menstrual cycle is defined as having a mean interval of 28 ± 7 days with a men duration of 4 ± 3 days. The upper limit of normal menstruation is 80 ml per menstruation. Any deviation from the normal cycle and the amount of loss is regarded as abnormal uterine bleeding. Dysfunctional uterine bleeding (DUB) is one of the commonest causes of abnormal uterine bleeding. It is defined as heavy and/or irregular menstruation in the absence of detectable pelvic pathology, pregnancy or general bleeding disorder. It affects 20 to 30 % of women and accounts for 12 % of gynecological referrals. DUB can be ovulatory or anovulatory. Anovulatory DUB occurs at extreme reproductive age (adolescence and peri-menopausal age)

show abstract

Transcervical resection of endometrium and fibroids: The outcome of 412 operations performed over 5 years

Abstract: Endometrial resection is safe and acceptable treatment option for both menorrhagia and metrorrhagia associated with dysmenorrhoea.

Cited by 38 publications

References 21 publications

Experience with Isotonic 2.2% Glycine as Distension Medium for Hysteroscopic Endomyometrial Resection

Experience with Isotonic 2.2% Glycine as Distension Medium for Hysteroscopic Endomyometrial Resection

Redução Endometrial por Vídeo-Histeroscopia: experiência em um Hospital de Ensino

The Use of Levonorgestrel-Releasing System (Metraplant-E) in the Treatment of Abnormal Uterine Bleeding

Contact Info

Product

Resources

About